Background We previously reported a PI3K inhibitor “type”:”entrez-protein” attrs :”text”:”S14161″ term_id :”98844″ term_text :”pirS14161 which displays a promising preclinical activity against multiple myeloma (MM) and leukemia but the chiral structure and poor solubility prevent its further application. and inhibition of PI3K were analyzed by flow cytometry and Western blotting respectively; anti-myeloma activity was performed on… Continue reading Background We previously reported a PI3K inhibitor “type”:”entrez-protein” attrs :”text”:”S14161″ term_id